Connection

Mark Kindy to Calcium-Calmodulin-Dependent Protein Kinase Type 2

This is a "connection" page, showing publications Mark Kindy has written about Calcium-Calmodulin-Dependent Protein Kinase Type 2.
  1. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. J Biol Chem. 2010 Jul 02; 285(27):20675-82.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.